Tolvaptan 15MG X7/ 45MG X7 dose
Ended Awarded
- Contract number
- 36C24921N0165
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 9
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $10,035
Award facts
- Contract value 100% obligated
- $10,034.63 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
About this award
Otsuka America Pharmaceutical Inc. received a $10,034.63 delivery order from Veterans Integrated Service Network 9 (VISN 9) on October 20, 2020, for Tolvaptan in two dosage strengths: 15mg (seven units) and 45mg (seven units). The contract is structured as a firm fixed-price delivery order under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) with performance in Potomac, Maryland and an ultimate completion date of October 27, 2020. No set-aside designation was utilized for this award, reflecting the competitive nature of the procurement.
This delivery order is issued against Otsuka America Pharmaceutical Inc.'s larger Blanket Purchase Agreement with the Department of Veterans Affairs, which carries an $83.3 million ceiling value through March 26, 2026. Tolvaptan, marketed as Jynarque, is a specialty pharmaceutical used to treat autosomal dominant polycystic kidney disease and hyponatremia in veteran populations. The award supports the VA's Veterans Health Administration mission to provide specialized pharmaceutical treatments to eligible veterans across the United States through streamlined procurement mechanisms under established master contracts.
Quick answers
Who was awarded contract 36C24921N0165?
36C24921N0165 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 9 (Veterans Health Administration) on October 20, 2020.
How much is contract 36C24921N0165 worth?
The government has obligated $10,035 on 36C24921N0165.
Is contract 36C24921N0165 an order under another contract?
Yes. 36C24921N0165 is a delivery order under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24921N0165 competed?
The extent of competition for 36C24921N0165 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award